The quantitative detection of aripiprazole and its main metabolite by using capillary-electrophoresis

Journal of the Chinese Medical Association

Volumn 74, Issue 6, 2011, Pages 267-271

  Tsai, Chia Jui ^b   Yu, Yen Hsin ^a   Chiu, Hsien Jane ^a,c,e   Loh, El Wui ^d   Wang, Jau Tay ^a   Chan, Chin Hong ^b   Lan, Tsuo Hung ^a,b,c,d  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c Yuli Hospital Department of Health Taiwan   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e Jianan Mental Hospital   (Taiwan)

Author keywords

Aripiprazole; Capillary electrophoresis; Dehydroaripiprazole; Detection

Indexed keywords

ARIPIPRAZOLE; BUFFER; DEHYDROARIPIPRAZOLE; DIMETHYL SULFOXIDE; DRUG METABOLITE; OPC 14857; PHOSPHATE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CAPILLARY ELECTROPHORESIS; COST; DRUG BLOOD LEVEL; DRUG DETERMINATION; HUMAN; PH; SCHIZOPHRENIA; TEMPERATURE;

ANTIPSYCHOTIC AGENTS; CALIBRATION; ELECTROPHORESIS, CAPILLARY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; PIPERAZINES; QUINOLONES;

EID: 79957446835     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2011.04.006     Document Type: Article

References (21)

1. Nelson J.C., Pikalov A., Berman R.M. Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatr Dis Treat 2008, 4:937-948.
2. Huang H.C., Liu C.H., Lan T.H., Hu T.M., Chiu H.J., Wu Y.C., et al. Detection and quantification of aripiprazole and its metabolite, dehydroaripiprazole, by gas chromatography-mass spectrometry in blood samples of psychiatric patients. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 856:57-61.
3. Tracy S.H., Carolin M.P. Aripiprazole: review of its use in schizophrenia and schizoaffective disorder. Drugs 2004, 64:1715-1736.
4. Jordan S., Chen R., Koprivica V., Tottori K., Kikuchi T., Altar C.A. The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor. Eur J Pharmacol 2002, 441:137-140.
5. Tadori Y., Kitagawa H., Forbes R.A., McQuade R.D., Stark A., Kikuchi T. Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912. Eur J Pharmacol 2007, 574:103-111.
6. Tadori Y., Forbes R.A., McQuade R.D., Kikuchi T. Characterization of aripiprazole partial agonist activity at human dopamine D3 receptors. Eur J Pharmacol 2008, 597:27-33.
7. Naber D., Lambert M. Aripiprazole: a new atypical antipsychotic with a different pharmacological mechanism. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:1213-1219.
8. Musenga A., Saracino M.A., Spinelli D., Rizzato E., Boncompagni G., Kenndler E., et al. Analysis of the recent antipsychotic aripiprazole in human plasma by capillary electrophoresis and high-performance liquid chromatography with diode array detection. Anal Chim Acta 2008, 612:204-211.
9. Shimokawa Y., Akiyama H., Kashiyama E., Koga T., Miyamoto G. High performance liquid chromatographic methods for the determination of aripiprazole with ultraviolet detection in rat plasma and brain: application to the pharmacokinetic study. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 821:8-14.
10. Lancelin F., Djebrani K., Tabaouti K., Kraoul L., Brovedani S., Paubel P., et al. Development and validation of a high-performance liquid chromatography method using diode array detection for the simultaneous quantification of aripiprazole and dehydro-aripiprazole in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 867:15-19.
11. Choong E., Rudaz S., Kottelat A., Guillarme D., Veuthey J.L., Eap C.B. Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC-MS. J Pharm and Biomed Anal 2009, 50:1000-1018.
12. Kirchherr H., Kühn-Velten W.N. Quantitative determination of forty-eight antidepressants and antipsychotics in human serum by HPLC tandem mass spectrometry: a multi-level, single-sample approach. J Chromatogr B Analyt Technol Biomed Life Sci 2006, 843:100-113.
13. Kubo M., Mizooku Y., Hirao Y., Osumi T. Development and validation of an LC-MS/MS method for the quantitative determination of aripiprazole and its main metabolite, OPC-14857, in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2005, 822:294-299.
14. Song M., Xu X., Hang T., Wen A., Yang L. Development of an LC-MS/MS method for the simultaneous quantification of aripiprazole and dehydroaripiprazole in human plasma. Anal Biochem 2009, 385:270-277.
15. Li K.Y., Zhou Y.G., Ren H.Y., Wang F., Zhang B.K., Li H.D. Ultra-performance liquid chromatography-tandem mass spectrometry for the determination of atypical antipsychotics and some metabolites in in vitro samples. J Chromatogr B Analyt Technol Biomed Life Sci 2007, 850:581-585.
16. Wätzig H., Günter S. Capillary electrophoresis: high-performance analytical separation technique. Clin Chem Lab Med 2003, 41:724-738.
17. Chou Y.W., Huang W.S., Chen C.C., Lin S.J., Wu H.L., Chen S.H. Trace analysis of zotepine and its active metabolite in plasma by capillary electrophoresis with solid phase extraction and head-column field-amplified sample stacking. J Chromatogr A 2005, 1087:189-196.
18. Farina C., Kremser L., Raggi M.A., Kenndler E. Determination of ziprasidone in pharmaceutical formulations by capillary zone electrophoresis. J Pharm Biomed Anal 2008, 46:471-476.
19. Hillaert S., Snoeck L., Van den Bossche W. Optimization and validation of a capillary zone electrophoretic method for the simultaneous analysis of four atypical antipsychotics. J Chromatogr A 2004, 1033:357-362.
20. Raggi M.A., Bugamelli F., Mandrioli R., Sabbioni C., Volterra V., Fanali S. Rapid capillary electrophoretic method for the determination of clozapine and desmethylclozapine in human plasma. J Chromatogr A 2001, 916:289-296.
21. Uzun S., Kozumplik O., Mimica N., Folnegović-Smalc V. Aripiprazole: an overview of a novel antipsychotic. Psychiatr Danub 2005, 17:67-75.